Mu-yang Huang

State Key Laboratory Of Quality Research In Chinese Medicine
Macao, 999078, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment.

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 07, 2025

Xerophenone H, a naturally-derived proteasome inhibitor, triggers apoptosis and paraptosis in lung cancer.

Xerophenone H, a naturally-derived proteasome inhibitor, triggers apoptosis and paraptosis in lung cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 18, 2024

Ginsenoside Rh2 in combination with IFNγ potentiated the anti-cancer effect by enhancing interferon signaling response in colorectal cancer cells.

Ginsenoside Rh2 in combination with IFNγ potentiated the anti-cancer effect by enhancing interferon signaling response in colorectal cancer cells.

Journal: Acta pharmacologica Sinica

Published: October 24, 2024

Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.

Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 01, 2024

Paraptosis: a non-classical paradigm of cell death for cancer therapy.

Paraptosis: a non-classical paradigm of cell death for cancer therapy.

Journal: Acta pharmacologica Sinica

Published: June 20, 2023

Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10.

Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10.

Journal: Pharmacological research

Published: May 29, 2023

Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives.

Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives.

Journal: Acta pharmaceutica Sinica. B

Published: June 20, 2022

Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis.

Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis.

Journal: MedComm

Published: March 23, 2022

Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.

Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.

Journal: Biochemical pharmacology

Published: November 19, 2021

Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies.

Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies.

Journal: Current cancer drug targets

Published: September 08, 2021

c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2.

c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2.

Journal: Acta pharmaceutica Sinica. B

Published: June 17, 2021

Regulation of CD47 expression by interferon-gamma in cancer cells.

Regulation of CD47 expression by interferon-gamma in cancer cells.

Journal: Translational oncology

Published: April 20, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026